ResMed Debuts MaskSelector, a Digital Tool for Remote CPAP Mask Fittings
18 May 2020 - 11:00PM
Business Wire
55% of HME respondents say mask selection is
the biggest challenge during remote CPAP setups in a recent
survey
ResMed (NYSE: RMD, ASX: RMD) has launched ResMed MaskSelector, a
digital tool to make remote patient mask selection and sizing
easier and more effective, helping patients receive the care they
need from home.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200518005130/en/
ResMed MaskSelector - Patient welcome
screen (Photo: Business Wire)
ResMed MaskSelector creates personalized ResMed mask
recommendations based on a patient’s sleep attributes and facial
measurements. An HME can provide a HIPAA-compliant single-use link
via text or email to a patient, who then answers a brief
questionnaire and enters three facial measurements into the ResMed
MaskSelector portal. Based on the patient’s responses, the tool
will recommend one of ResMed’s industry-leading masks, along with
options for alternate ResMed mask models and sizes.
HMEs say they need better remote capabilities to fit and select
masks for patients during the COVID-19 pandemic, according to a
recent survey of roughly 300 clinicians. Fifty-five percent of
respondents stated mask selection was the area in which they either
experienced or expected the most challenges with remote setup
patients. Additionally, 54 percent said they were likely to
continue offering remote CPAP setups to their new patients in the
future.
“ResMed MaskSelector is the digital health technology solution
to HMEs’ challenge of finding the right mask for each patient when
they can’t physically see them due to physical distancing,” said
Jim Hollingshead, ResMed Sleep president. “Mask fit and comfort is
key to a new CPAP user’s therapy success, and this online tool
helps clinicians find the best option for their patients – today
and long after this pandemic ends.”
MaskSelector is available starting today to most HMEs in the
U.S. It is being offered at no charge now through December 31 to
help HMEs serve their patients during the COVID-19 public health
emergency. Interested HMEs should contact their ResMed Solutions
Consultant or Sales representative.
Visit ResMed.com/MaskSelector to learn more.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our digital health
technologies and cloud-connected medical devices transform care for
people with sleep apnea, COPD, and other chronic diseases. Our
comprehensive out-of-hospital software platforms support the
professionals and caregivers who help people stay healthy in the
home or care setting of their choice. By enabling better care, we
improve quality of life, reduce the impact of chronic disease, and
lower costs for consumers and healthcare systems in more than 140
countries. To learn more, visit ResMed.com and follow @ResMed.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200518005130/en/
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
Resmed (ASX:RMD)
Historical Stock Chart
From Oct 2024 to Nov 2024
Resmed (ASX:RMD)
Historical Stock Chart
From Nov 2023 to Nov 2024